| 1. |
- Cunningham, John A, et al.
(författare)
-
Beliefs about drinking problems : Results from a general population telephone survey
- 2007
-
Ingår i: Addictive Behaviors. ; 32:1, s. 166-169
-
Tidskriftsartikel (refereegranskat)abstract
- As part of a general population telephone survey (N = 3006), respondents were asked their beliefs about alcohol problems. The majority of respondents were skeptical about the possibility of untreated and of moderate drinking recoveries. The predominant conceptions of the nature of alcohol problems were those of a disease or of drug addiction. Beliefs about the need for treatment and abstinence were positively associated with being female, older, and married. Current heavy drinkers were less likely to believe that treatment was needed. Former heavy drinkers were more likely to believe that abstinence was required, as compared to all other respondents.
|
|
| 2. |
- Cunningham, Joanne, et al.
(författare)
-
Radiation Oncology Safety Information System (ROSIS) - Profiles of participants and the first 1074 incident reports
- 2010
-
Ingår i: Radiotherapy and Oncology. - : Elsevier BV. - 1879-0887 .- 0167-8140. ; 97:3, s. 601-607
-
Tidskriftsartikel (refereegranskat)abstract
- Background and purpose: The Radiation Oncology Safety Information System (ROSIS) was established in 2001. The aim of ROSIS is to collate and share information on incidents and near-incidents in radiotherapy, and to learn from these incidents in the context of departmental infrastructure and procedures. Materials and methods: A voluntary web-based cross-organisational and international reporting and learning system was developed (cf. the www.rosis.info website). Data is collected via online Department Description and Incident Report Forms. A total of 101 departments, and 1074 incident reports are reviewed. Results: The ROSIS departments represent about 150,000 patients, 343 megavoltage (MV) units, and 114 brachytherapy units. On average, there are 437 patients per MV unit, 281 per radiation oncologist, 387 per physicist and 353 per radiation therapy technologist (RT/RTT). Only 14 departments have a completely networked system of electronic data transfer, while 10 departments have no electronic data transfer. On average seven quality assurance (QA) or quality control (QC) methods are used at each department. A total of 1074 ROSIS reports are analysed; 97.7% relate to external beam radiation treatment and 50% resulted in incorrect irradiation. Many incidents arise during pre-treatment but are not detected until later in the treatment process. Where an incident is not detected prior to treatment, an average of 22% of the prescribed treatment fractions were delivered incorrectly. The most commonly reported detection methods were "found at time of patient treatment" and during "chart-check". Conclusion: While the majority of the incidents that reported to this international cross-organisational reporting system are of minor dosimetric consequence, they affect on average more than 20% of the patient's treatment fractions. Nonetheless, defence-in-depth is apparent in departments registered with ROSIS. This indicates a need for further evaluation of the effectiveness of quality controls. (C) 2010 Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 97 (2010) 601-607
|
|
| 3. |
- Cunningham, Joanne, et al.
(författare)
-
Update on research and treatment of premenstrual dysphoric disorder.
- 2009
-
Ingår i: Harvard review of psychiatry. - : Ovid Technologies (Wolters Kluwer Health). - 1465-7309 .- 1067-3229. ; 17:2, s. 120-37
-
Tidskriftsartikel (refereegranskat)abstract
- Many women in their reproductive years experience some mood, behavioral. or physical symptoms in the week prior to menses. Variability exists in the level of symptom burden in that some women experience mild symptoms, whereas a small minority experience severe and debilitating symptoms. For an estimated 5%-8% of premenopausal women, work or social functioning are affected by severe premenstrual syndrome. Many women in this group meet diagnostic criteria for premenstrual dysphoric disorder (PMDD). Among women who suffer from PMDD, mood and behavioral symptoms such as irritability, depressed mood, tension, and labile mood dominate. Somatic complaints, including breast tenderness and bloating, also can prove disruptive to women's overall functioning and quality of life. Recent evidence suggests that individual sensitivity to cyclical variations in levels of gonadal hormones may predispose certain women to experience these mood, behavioral, and somatic symptoms. Treatments include: antidepressants of the serotonin reuptake inhibitor class, taken intermittently or throughout the menstrual cycle; medications that suppress ovarian cyclicity; and newer oral contraceptives with novel progestins.
|
|
| 4. |
- Marr, Edward J, et al.
(författare)
-
An enhanced toolkit for the generation of knockout and marker-free fluorescent Plasmodium chabaudi
- 2020
-
Ingår i: Wellcome open research. - : Wellcome open research. - 2398-502X. ; 5
-
Tidskriftsartikel (refereegranskat)abstract
- The rodent parasite Plasmodium chabaudi is an important in vivo model of malaria. The ability to produce chronic infections makes it particularly useful for investigating the development of anti- Plasmodium immunity, as well as features associated with parasite virulence during both the acute and chronic phases of infection. P. chabaudi also undergoes asexual maturation (schizogony) and erythrocyte invasion in culture, so offers an experimentally-amenable in vivo to in vitro model for studying gene function and drug activity during parasite replication. To extend the usefulness of this model, we have further optimised transfection protocols and plasmids for P. chabaudi and generated stable, fluorescent lines that are free from drug-selectable marker genes. These mother-lines show the same infection dynamics as wild-type parasites throughout the lifecycle in mice and mosquitoes; furthermore, their virulence can be increased by serial blood passage and reset by mosquito transmission. We have also adapted the large-insert, linear PlasmoGEM vectors that have revolutionised the scale of experimental genetics in another rodent malaria parasite and used these to generate barcoded P. chabaudi gene-deletion and -tagging vectors for transfection in our fluorescent P. chabaudi mother-lines. This produces a tool-kit of P. chabaudi lines, vectors and transfection approaches that will be of broad utility to the research community.
|
|
